Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
25
25 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ObrixtamigBI 764532Phase 36 trials
Boehringer Ingelheim · Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology
- VicadrostatBI 690517Phase 35 trials
Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension
- VerducatibBI 1291583Phase 34 trials
Boehringer Ingelheim · Bronchiectasis, Chronic Obstructive Pulmonary Disease
- BI 764198ApecotrepPhase 33 trials
Boehringer Ingelheim · Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases, Kidney Disease, Chronic
- BrigimadlinBI 907828Phase 33 trials
Boehringer Ingelheim · Solid Tumours, Pancreatic Neoplasms, Solid Tumors
- SurvodutideBI 456906Phase 33 trials
Boehringer Ingelheim · Obesity, Type 2 Diabetes, Overweight
- ZL-1310Phase 33 trials
Zai Lab (Shanghai) Co., Ltd. · Solid Tumors, Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma
- BI 1015550Phase 32 trials
Boehringer Ingelheim · Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis
- EzabenlimabBI 754091Phase 32 trials
Boehringer Ingelheim · Advanced Cancer, Neoplasm Metastasis, Advanced Tumors
- BI 1569912Phase 22 trials
Boehringer Ingelheim · Depressive Disorder, Major
- BI 1584862Phase 21 trial
Boehringer Ingelheim · Geographic Atrophy
- BI 1815368Phase 21 trial
Boehringer Ingelheim · Macular Edema
- BI 1819479Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 3000202Phase 21 trial
Boehringer Ingelheim · Systemic Lupus Erythematosus
- BI 3032950Phase 21 trial
Boehringer Ingelheim · Ulcerative Colitis
- BI 3034701Phase 21 trial
Boehringer Ingelheim · Obesity, Overweight
- BI 3802876Phase 21 trial
Boehringer Ingelheim · Liver Cirrhosis
- BI 3810477Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 3812465Phase 21 trial
Boehringer Ingelheim · Diabetic Macular Edema
- BI 754111Phase 21 trial
Boehringer Ingelheim · Neoplasm Metastasis, Advanced Tumors, Metastatic Solid Tumors
- BI 764524Phase 21 trial
Boehringer Ingelheim · Diabetic Retinopathy
- BI 765423Phase 21 trial
Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis
- BI 770371Phase 21 trial
Boehringer Ingelheim · Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)
- BI 771716Phase 21 trial
Boehringer Ingelheim · Macular Degeneration, Age-related, Geographic Atrophy
- BI 836880Phase 21 trial
Boehringer Ingelheim · Neoplasm Metastasis, Advanced Tumors, Metastatic Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.